These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 23626465)
1. Hemostatic absorbable gelatin sponge loaded with 5-fluorouracil for treatment of tumors. Sun W; Chen Y; Yuan W Int J Nanomedicine; 2013; 8():1499-506. PubMed ID: 23626465 [TBL] [Abstract][Full Text] [Related]
2. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies. Li X; Xu Y; Chen G; Wei P; Ping Q Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762 [TBL] [Abstract][Full Text] [Related]
3. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets. Leelakanok N; Geary SM; Salem AK J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952 [TBL] [Abstract][Full Text] [Related]
4. Effective sustained release of 5-FU-loaded PLGA implant for improving therapeutic index of 5-FU in colon tumor. Li L; Li C; Zhou J Int J Pharm; 2018 Oct; 550(1-2):380-387. PubMed ID: 30040972 [TBL] [Abstract][Full Text] [Related]
5. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Nair K L; Jagadeeshan S; Nair SA; Kumar GS Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233 [TBL] [Abstract][Full Text] [Related]
6. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors. Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485 [TBL] [Abstract][Full Text] [Related]
7. Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil. Leelakanok N; Geary S; Salem A J Pharm Sci; 2018 Feb; 107(2):513-528. PubMed ID: 29045885 [TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy. Lin Y; Li Y; Ooi CP J Mater Sci Mater Med; 2012 Oct; 23(10):2453-60. PubMed ID: 22843166 [TBL] [Abstract][Full Text] [Related]
9. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model. Safwat MA; Soliman GM; Sayed D; Attia MA Mol Pharm; 2018 Jun; 15(6):2194-2205. PubMed ID: 29701979 [TBL] [Abstract][Full Text] [Related]
10. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel. Yi H; Cho HJ; Cho SM; Lee DG; Abd El-Aty AM; Yoon SJ; Bae GW; Nho K; Kim B; Lee CH; Kim JS; Bartlett MG; Shin HC BMC Cancer; 2010 May; 10():211. PubMed ID: 20482808 [TBL] [Abstract][Full Text] [Related]
12. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. Menei P; Boisdron-Celle M; Croué A; Guy G; Benoit JP Neurosurgery; 1996 Jul; 39(1):117-23; discussion 123-4. PubMed ID: 8805147 [TBL] [Abstract][Full Text] [Related]
13. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles. Rajan M; Raj V; Al-Arfaj AA; Murugan AM Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828 [TBL] [Abstract][Full Text] [Related]
14. In vivo distribution of 5-Fluorouracil after peritumoral implantation using a biodegradable micro-device in tumor-bearing mice. Zheng N; Zhou M; Lu W Eur J Drug Metab Pharmacokinet; 2013 Sep; 38(3):183-90. PubMed ID: 23179563 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique. Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. Li S; Wang A; Jiang W; Guan Z BMC Cancer; 2008 Apr; 8():103. PubMed ID: 18412945 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide). Wang G; Tucker IG; Roberts MS; Hirst LW Pharm Res; 1996 Jul; 13(7):1059-64. PubMed ID: 8842045 [TBL] [Abstract][Full Text] [Related]
18. Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer. Liu J; Meisner D; Kwong E; Wu XY; Johnston MR Cancer Res; 2009 Feb; 69(3):1174-81. PubMed ID: 19176391 [TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers. Sastre RL; Olmo R; Teijón C; Muñíz E; Teijón JM; Blanco MD Int J Pharm; 2007 Jun; 338(1-2):180-90. PubMed ID: 17336474 [TBL] [Abstract][Full Text] [Related]
20. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy. Gao Z; Li Z; Yan J; Wang P Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]